ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma

Hrain Biotechnology Co., Ltd. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
b-cell non-hodgkin's lymphoma, cd19, car-t, relapsed/refractory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 895353
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.